BE YOURSELF
THE MiniMed® 670G
WITH
SmartGuard®
AUTO MODE
Minimed 670G
subscription launch
6 Month GS3 CGM Subscription
+ Guardian™ 3 Link Transmitter
All for just $125 a month*
*Terms and conditions apply
more time to be you
Living life more spontaneously.
Instead of injecting insulin many times a day, the MiniMed® 670G System^ helps keep your sugar levels safely in range based on how you live every day. *#
Enjoying meals without interruption.
Instead of figuring out complex insulin dose on your own, simply check your glucose and enter the number of carbs when you give a mealtime bolus. The MiniMed® 670G System^ assists with the rest, automatically∞ adjusting insulin while you enjoy your meal without interruption. *#
Sleeping soundly. Waking up energised.
The MiniMed® 670G System^ lets you wake up every morning well-rested and ready to take on the day.
Having more time for family and friends.
Now you can spend less time worrying and more time bonding with family and friends. To help you stay in range, the MiniMed® 670G System^ delivers insulin based on your sugar levels 24 hours a day with minimal input and periodic sensor calibration. *,#,‡
BELTS AND POUCHES
Soft belts and pouches can be sized for the perfect fit and give you a comfortable way to keep your pump close and concealed. They can be worn on different parts of your body - the arm, waist, thigh or leg - discreetly under clothing.
CASES AND CLIPS
With our selection of cases and clips, there are many ways to wear your insulin pump. You can attach your pump to your waistband or belt, protect it in your pocket, or even clip it under your clothing.
Inspiring news. read all about it.
“A life-changing breakthrough.”
“This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time.”
“Automated insulin delivery system will ease some of the burden of living with the condition”
One of “the 25 best inventions of 2016”
Request a call today, to discuss the benefits of an Insulin Pump Therapy with a Medtronic Diabetes Therapy Consultant.
Be sure to discuss questions specific to your health and treatments with a healthcare professional.
^ Components sold separately. Automated insulin delivery is made possible through combining Medtronic insulin pump and continuous glucose monitoring technology.
‡Mean Absolute Relative Difference.
# Based on sensor glucose.
Clinical references
1. Bailey T, et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR®NEXT LINK 2.4 Blood Glucose Monitoring System. Poster presented at the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2014 February 5–8, Vienna, Austria.
Indications
The MiniMed 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of Type 1 diabetes mellitus in persons age seven and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G system includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM), and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The Guardian Sensor (3) is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the Guardian Sensor (3).
Warnings
Important Safety Information: MiniMed™ 670G System
The safety of using Auto Mode, Suspend before low, and Suspend on low in people who have no pump experience is not known. Auto Mode, Suspend before low, and Suspend on low should not be used if insulin pump settings have not been previously established. Insulin pump settings include basal rates, insulin to carb ratio, or insulin sensitivity factors. Always discuss with your healthcare professional before using Auto Mode, Suspend before low, or Suspend on low.
Do not make treatment decisions, such as determining your insulin dose for meals, using the MiniMed 670G system CGM values, as they are not intended to be used to make such treatment decisions. The MiniMed 670G system CGM does not replace a BG meter. Always use the values from your BG meter for treatment decisions. BG values may differ from SG values. Using the SG readings for treatment decisions could lead to high or low BG.
Do not use Auto Mode for a period of time after giving a manual injection of insulin by syringe or pen. Manual injections are not accounted for in Auto Mode. Therefore, Auto Mode could deliver too much insulin. Too much insulin may cause hypoglycaemia. Consult with your healthcare professional for how long you need to wait after a manual injection of insulin before you resume Auto Mode.
The MiniMed 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of Type 1 diabetes mellitus in persons age seven and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G system includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM), and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Guardian Sensor (3) is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the Guardian Sensor (3).
Contraindications
Medtronic performed an evaluation of the MiniMed 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.
